CU Innovations brings together some of the greatest minds of several academic fields at the University of Colorado Anschutz Medical Campus and beyond to work across disciplines to benefit health and wellness in the larger communities. In today’s episode of the President’s Innovation Podcast, a CU on the Air series, we talk with Kimberly Muller, executive director of CU Innovations about the remarkable breakthrough that are already benefiting society, and the great work to come.

* CU Innovations was started five years ago by Muller and Steven Nordeen to fulfill Chancellor Don Elliman’s vision for how would you redesign define innovation at an academic medical center.
* CU Innovations looks to create or partner with companies who are going to redefine care delivery, redefine how we receive care, so that we can improve outcomes both for our physicians, our patients, and to lower the overall cost of care.
* How this science benefited COVID research.
* With hospital partners, Children’s Hospital Colorado, and the UCHealth system, CU Innovations has established a living clinical laboratory for testing and validating the best health care technologies wherever they may exist throughout the country.
* Over the past four years, the department has had over 600 companies from around the United States come to Colorado to partner with it to think about how are we going to take these technologies and actually get them utilized at the point of care.
* CU’s role in the technology utilized in JSK is multi-billion dollar Shingrix vaccine.
* To help startups, CU Innovations has created a fund that can invest in these companies and clinical tests that are needed in order to validate the viable, leading-edge ideas.
* The Health Care Innovation Fund is the first venture fund in the uUniversity of Colorado history. It was able to raise $50 million in less than six months.
* RX Review is helping to figure out how to get the right drug to the right patient at the right time at a cost for which that they could actually afford the medication.
* Outside advisers include serial entrepreneur Stan Lapidus, who helps with business models and projected outcomes throughout the inception-implementation of new research.
* Shi-Long Lu and Lapidus developed a new diagnostic for head and neck cancer. They started a company together and that technology was actually saliva based diagnostics for head and neck cancer.
* CU innovations is looking to expand what it does around novel therapeutics, using a data-driven approach to innovation, what we have as a unique data infrastructure at the Anschutz medical campus.

Resources

* CU Innovations
* CU Anschutz Medical Campus
* RX Revu